Roche Holding Ltd. (ROG) Rating Reiterated by J P Morgan Chase & Co
Several other brokerages also recently commented on ROG. HSBC Holdings plc set a CHF 203 price objective on Roche Holding and gave the stock a sell rating in a research note on Friday, October 20th. Sanford C. Bernstein set a CHF 284 price objective on Roche Holding and gave the stock a buy rating in a research note on Tuesday, July 18th. Berenberg Bank set a CHF 260 price objective on Roche Holding and gave the stock a neutral rating in a research note on Tuesday, October 24th. Goldman Sachs Group, Inc. (The) set a CHF 325 target price on Roche Holding and gave the stock a buy rating in a report on Monday, September 11th. Finally, Deutsche Bank AG set a CHF 260 target price on Roche Holding and gave the stock a neutral rating in a report on Friday, July 7th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and five have given a buy rating to the company’s stock. Roche Holding currently has a consensus rating of Hold and a consensus target price of CHF 263.
Shares of Roche Holding (VTX:ROG) opened at CHF 232.50 on Thursday. Roche Holding has a 12 month low of CHF 218.30 and a 12 month high of CHF 273.
TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/11/06/roche-holding-ltd-rog-rating-reiterated-by-j-p-morgan-chase-co.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.